The Simcere Pharmaceutical Group has won seven honors in the 2018 China Chemical-pharmaceutical Industry Outstanding Enterprises and Excellent Product Brand List.

On October 16, 2018, the 2018' China Chemical-Pharmaceutical Industry Annual Summit was held in Nanjing. During the conference, the China Chemical-pharmaceutical Industry Outstanding Enterprises and Excellent Product Brand List was released. Approved by the Brand Recommendations Expert Committee, Simcere ranked No. 20 with regard to the overall strength among top 100 China's chemical-pharmaceutical industry enterprises. 

Meanwhile, 6 of Simcere’s products were listed in the 6 categories of excellent product brands: "Recombinant Human Endostatin (tradename: Endo) - anti-tumor and immunomodulator", "Edaravone Injection" (tradename: Bicun® – neurology and psychiatry system", "Biapenem For Injection (trade name: Anxin®) - anti-infection", "Rosuvastatin Calcium Tablets (trade name: Shufutan®) - Blood lipids modulator, "Montmorillonite Powder (trade name: Biqi®) - digestive system", "Amoxicillin Granules (trade name: Zailin®) - pediatric medication".









Related News